Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. (SHA:688076)
China flag China · Delayed Price · Currency is CNY
27.22
-0.30 (-1.09%)
Nov 17, 2026, 3:00 PM CST

SHA:688076 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
2,1631,9431,6251,034651.29643.87
Revenue Growth
13.86%19.57%57.21%58.69%1.15%13.58%
Gross Profit
1,0951,1331,050589.28343.36337.57
Operating Income
475.45464.03460.86191.0471.78117.1
Net Income
223332.42404.39162.94129.11115.39
Earnings Per Share
0.711.061.310.540.440.43
EPS Growth
-56.10%-19.08%141.30%24.60%1.66%-22.07%

Revenue by Geography

Fiscal Year
FY 2025
Period EndingDec '25
Overseas
1,366
China
576.96
Total
1,943

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,1551,030779.39749.08442.98679.01
Total Debt
2,8062,6601,642895.07320.1983.65
Net Cash (Debt)
-1,651-1,630-863.06-145.98122.79595.36
Net Cash Growth
-----79.38%-
Net Cash Per Share
-5.23-5.20-2.80-0.490.412.21

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
1,010681.24400.12350.2129.29180.75
Capital Expenditures
-856.44-1,367-1,090-660.64-438.36-233.36
Free Cash Flow
153.12-685.77-690.01-310.43-409.07-52.61
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
50.60%58.34%64.61%57.02%52.72%52.43%
Operating Margin
21.98%23.89%28.36%18.48%11.02%18.19%
Pretax Margin
11.16%18.56%26.99%16.75%18.91%19.53%
Profit Margin
10.31%17.11%24.89%15.77%19.82%17.92%
FCF Margin
7.08%-35.30%-42.47%-30.04%-62.81%-8.17%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.3500.3500.6430.2860.1430.107
Dividend Per Share Growth
-56.25%-45.56%125.03%99.93%33.43%-
Dividend Yield
1.29%0.93%1.73%0.89%0.87%0.36%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
38.5635.8428.2258.8137.8876.36
Forward PE
-17.4420.2550.6531.8642.28
PS Ratio
3.996.137.029.277.5113.68